Measurement of transferrin receptor kinetics in the baboon liver using dynamic positron emission tomography imaging and [18F]holo-transferrin

Hepatology

Volumn 25, Issue 4, 1997, Pages 986-990

  Aloj, Luigi ^a   Carson, Richard E ^a   Lang, Lixin ^a   Herscovitch, Peter ^a   Eckelman, William C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FLUORINE 18; TRANSFERRIN RECEPTOR;

ARTICLE; BABOON; ISOTOPE LABELING; KINETICS; LIVER; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPLEEN;

ALBUMINS; ANIMALS; FLUORINE RADIOISOTOPES; HUMANS; LIVER; MODELS, BIOLOGICAL; PAPIO; RECEPTORS, TRANSFERRIN; TOMOGRAPHY, EMISSION-COMPUTED; TRANSFERRIN;

EID: 0031005049     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250432     Document Type: Article

References (21)

1. Wrigglesworth JM, Baum H. The biochemical functions of iron. In: Jacobs A, Worwood M, eds. Iron in Biochemistry and Medicine. Volume 1, Ed 1. London: Academic Press, 1980:29-86.
2. Testa U, Pelosi E, Peschle C. The transferrin receptor. Grit Rev Oncog 1993;4:241-76.
3. Klausner RD, Ashwell G, Van Renswoude J, Harford JB, Bridges KR. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci U S A 1983;80:2263-2266.
4. Dautry-Varsat A, Ciechanover A, Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 1983;80:2258-2262.
5. Krishnamurthy R, Harford JB, Roualt T, McLelland A, Ruddle FH, Klausner RD. Transcriptional regulation by iron of the gene for the transferrin receptor. Mol Cell Biol 1986;6:236-240.
6. Bridges KR, Seligman PA. Disorders of iron metabolism. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Volume 1. Ed 1. Philadelphia: Lippincott, 1995:1433-1472.
7. Klausner RD, Van Renswoude J, Ashwell G, Kempf C, Schechter AN, Dean A, Bridges KR. Receptor-mediated endocytosis of transferrin in K562 cells. J Biol Chem 1983;258:4715-4724.
8. Aloj L, Lang L, Jagoda E, Neumann RD, Eckelman WC. The evaluation of human transferrin labeled with N-succinimidyl 4-[F-18] (fluoromethyl) benzoate. J Nucl Med 1996;37:1408-1412.
9. Aloj L, Carson RE, Lang L, Herscovitch P, Eckelman WC. Measurement of transferrin receptor kinetics in the liver using dynamic 3D-PET and [F-181 holo-transferrin [Abstract]. J Nucl Med 1996;37(Suppl):203P.
10. 18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. Appl Radiat Isot 1994;45:1155-1163.
11. Lang L, Eckelman WC. Labeling proteins at high specific activity using N-succinimidyl 4-IF-18] fluoromethyl benzoate. Appl Radiat Isot 1997;48:169-173.
12. Carson RE. Mathematical modeling and compartmental analysis. In: Harbert JC, Neumann RD, Eckelman WC, eds. Nuclear Medicine: Diagnosis and Therapy. Volume 1. Ed 1, New York: Thieme, 1996:167-193.
13. Beck JV, Arnold KJ. Parameter Estimation in Engineering and Science. New York: Wiley, 1977.
14. Sasaki K, Zak O, Aisen P. Antisense suppression of transferrin receptor gene expression in a human hepatoma cell (HuH-7) line. Am J Hematol 1993;42:74-80.
15. Thorstensen K, Romslo I. Uptake of iron from transferrin by isolated rat hepatocytes. A redox-mediated plasma membrane process? J Biol Chem 1988;263:8844-8850.
16. Bonkovsky HL. Iron and the liver. Am J Med Sci 1991;301:32-43.
17. Richardson DR, Baker E. The uptake of iron and transferrin by the human malignant melanoma cell. Biochim Biophys Acta 1990;1053:1-12.
18. Ciechanover A, Schwartz AL, Dautry-Varsat A, Lodish HF. Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem 1983;258:9681-9689.
19. Lemieux P, Page M. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate. Anticancer Res 1993;13:397-404.
20. Wellhoner HH, Neville DM Jr, Srinivasachar K, Erdmann G. Uptake and concentration of bioactive macromolecules by K562 cells via the transferrin cycle utilizing an acid-labile transferrin conjugate. J Biol Chem 1991;266:4309-4314.
21. Goldstein JL, Brown MS. Prevention and treatment of genetic disorders. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Principles of Internal Medicine. Volume 1. Ed 11. New York: McGraw-Hill, 1987:324-328.